Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Stem Cells ; 26(8): 2183-92, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18535154

RESUMO

Parkinson's disease is a complex disorder characterized by degeneration of dopaminergic neurons in the substantia nigra in the brain. Stem cell transplantation is aimed at replacing dopaminergic neurons because the most successful drug therapies affect these neurons and their synaptic targets. We show here that neural progenitors can be grown from the olfactory organ of humans, including those with Parkinson's disease. These neural progenitors proliferated and generated dopaminergic cells in vitro. They also generated dopaminergic cells when transplanted into the brain and reduced the behavioral asymmetry induced by ablation of the dopaminergic neurons in the rat model of Parkinson's disease. Our results indicate that Parkinson's patients could provide their own source of neuronal progenitors for cell transplantation therapies and for direct investigation of the biology and treatments of Parkinson's disease. Disclosure of potential conflicts of interest is found at the end of this article.


Assuntos
Dopamina/metabolismo , Mucosa Olfatória/metabolismo , Doença de Parkinson/metabolismo , Doença de Parkinson/terapia , Transplante de Células-Tronco/métodos , Animais , Biópsia , Encéfalo/metabolismo , Diferenciação Celular , Linhagem da Célula , Feminino , Humanos , Neurônios/metabolismo , Ratos , Ratos Sprague-Dawley , Transplante Autólogo
2.
PLoS One ; 7(8): e42482, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22879998

RESUMO

Abnormal dopamine (DA) signaling is often suggested as causative in schizophrenia. The other prominent hypothesis for this disorder, largely driven by epidemiological data, is that certain adverse events during the early stages of brain development increase an individual's risk of developing schizophrenia later in life. However, the clinical and preclinical literature consistently implicates behavioural, cognitive, and pharmacological abnormalities, implying that DA signaling is abnormal in the adult brain. How can we reconcile these two major hypotheses underlying much of the clinical and basic research into schizophrenia? In this study we have transiently knocked down tyrosine hydroxylase (TH, the rate limiting enzyme in DA synthesis) gene expression in the early stages of brain development in zebrafish using morpholinos. We show that by adulthood, TH and DA levels have returned to normal and basic DA-mediated behaviours, such as locomotion, are also normal. However, when they were exposed to a novel environment the levels of freezing and immediate positioning in deeper zones were significantly reduced in these adult fish. The neurochemistry underlying these behaviours is complex, and the exact mechanisms for these abnormal behaviours remains unknown. This study demonstrates that early transient alterations in DA ontogeny can produce persistent alterations in adult brain function and suggests that the zebrafish may be a promising model animal for future studies directed at clarifying the basic neurodevelopmental mechanisms behind complex psychiatric disease.


Assuntos
Envelhecimento/fisiologia , Comportamento Animal/fisiologia , Técnicas de Silenciamento de Genes , Tirosina 3-Mono-Oxigenase/genética , Peixe-Zebra/crescimento & desenvolvimento , Peixe-Zebra/fisiologia , Envelhecimento/efeitos dos fármacos , Animais , Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Encéfalo/patologia , Mergulho , Dopamina/metabolismo , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/metabolismo , Reação de Congelamento Cataléptica/efeitos dos fármacos , Habituação Psicofisiológica/efeitos dos fármacos , Larva/efeitos dos fármacos , Locomoção/efeitos dos fármacos , Morfolinos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA